Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Protein-Protein Interaction as an Efficient Target to Inhibit HIV-1 Integrase
Archiv Der Pharmazie
May 2026
Zarghi A.
Design, synthesis, molecular dynamics studies and biological evaluations of 4-hydroxy-5-pyrrolinone-3-carbohydrazides as HIV-1 integrase inhibitors
European Journal of Medicinal Chemistry Reports
December 2024
Karimi N.
Open Access
Computational investigation of Y. aloifolia variegate as anti-Human Immunodeficiency Virus (HIV) targeting HIV-1 protease: A multiscale in-silico exploration
Pharmacological Research Modern Chinese Medicine
June 2024
Irsal R.A.P.
Open Access
Comprehensive Review on Different Analytical Techniques for HIV 1- Integrase Inhibitors: Raltegravir, Dolutegravir, Elvitegravir and Bictegravir
Critical Reviews in Analytical Chemistry
2024
Jain P.
A Literature Review Focusing on the Antiviral Activity of [1,2,4] and [1,2,3]-triazoles
Mini Reviews in Medicinal Chemistry
2024
Farghaly T.A.
Recent Developments in the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors Incorporating Pyridine Moiety
International Journal of Molecular Sciences
June 2023
Starosotnikov A.M.
Open Access
Repurposing FDA-approved drugs as HIV-1 integrase inhibitors: an in silico investigation
Journal of Biomolecular Structure and Dynamics
2023
Ha C.H.X.
Design, Synthesis, Docking Studies, and Biological Evaluation of Novel 2-Hydroxyacetophenone Derivatives as Anti-HIV-1 Agents
Current HIV Research
2023
Oliaie S.S.
A Korean Post-Marketing Surveillance Study of Dolutegravir Single-Agent Tablets in Patients with HIV-1
Infection and Chemotherapy
December 2022
Kwon S.
Open Access
Synthesis, Biological Evaluation, and Molecular Modeling Studies of New 8-methyl-4-oxo-1,4-dihydroquinoline-3-carbohydrazides as Potential Anti-HIV Agents
Iranian Journal of Pharmaceutical Research
Dec 2022
Alemi M.
Open Access
Design, Synthesis, Docking Study, and Biological Evaluation of 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide Derivatives as Anti-HIV-1 and Antibacterial Agents.
Iranian Journal of Pharmaceutical Research
Dec 2022
Abdollahi O.
Open Access
Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors
European Journal of Medicinal Chemistry
5 October 2022
Valipour M.
All Open Access, Green
Design, Synthesis, and Docking Studies of Thioimidazolyl Diketoacid Derivatives Targeting HIV-1 Integrase
Medicinal Chemistry
May 2022
Karimi N.
Non-nucleoside structured compounds with antiviral activity—past 10 years (2010–2020)
European Journal of Medicinal Chemistry
5 March 2022
Denel-Bobrowska M.
All Open Access, Green
Piroxicam Analogs: Design, Synthesis, Docking Study and Biological Evaluation as Promising Anti-HIV-1 Agents
Medicinal Chemistry
February 2022
Imani A.
Design, Synthesis and Docking studies of New Quinazolinone Derivatives as Anti-HIV-1 Agents
Iranian Journal of Pharmaceutical Sciences
2022
Zebardast T.
Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation
Iranian Journal of Pharmaceutical Research
Jan 2022
Lotfaliei M.
Open Access
Recent advances in small-molecule HIV-1 integrase inhibitors
Current Medicinal Chemistry
July 2021
Zhang C.
Design, Synthesis, Docking Study and Biological Evaluation of 4-Hydroxy-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide Derivatives as Anti-HIV Agents
Iranian Journal of Pharmaceutical Research
July 2021
Imani A.
First report for the electrochemical investigation of a new HIV integrase inhibitor dolutegravir: Its voltammetric determination in tablet dosage forms and human urine using a boron-doped diamond electrode
Diamond and Related Materials
April 2021
Allahverdiyeva S.
HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies
Iranian Journal of Pharmaceutical Research
Spring 2021
Mahboubi-Rabbani M.
Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: Current status and future challenges
Future Medicinal Chemistry
February 2021
Kharkwal H.
Development and genetic drug resistance research of HIV-1 integrase inhibitors
China Tropical Medicine
2021
Liang M.R.
Bioactive Secondary Metabolites from Endophytic Phoma spp.
Phoma Diversity Taxonomy Bioactivities and Nanotechnology
1 January 2021
Mahish P.K.